The effect of miR-3163 on the Notch signaling pathway or sensitivity of HCC cells to sorafenib was almost blocked by transfection of mutated ADAM-17, the inhibitor of miR-3163, or NICD. This evidence concerns the gene ADAM17 and hepatocellular carcinoma.